Hims & Hers Health Inc.
07/22/2024 | Press release | Distributed by Public on 07/22/2024 14:36
Management Change/Compensation Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On July 16, 2024, the board of directors (the "Board") of Hims & Hers Health, Inc. (the "Company") increased the size of the Board from eight to nine directors and appointed Kåre Schultz, 63, to fill the newly created vacancy, effective immediately. Mr. Schultz will serve until the Company's 2025 annual meeting of stockholders and until his successor is elected and qualified, or sooner in the event of his death, resignation or removal. The Board has determined that Mr. Schultz meets the requirements for independence under the applicable listing standards of the New York Stock Exchange and the Securities Exchange Act of 1934, as amended. The Board has not yet appointed Mr. Schultz to any Board committees.
Mr. Schultz will be entitled to receive compensation as outlined in the "Director Compensation" section in the Company's proxy statement filed with the Securities and Exchange Commission on April 26, 2024. Mr. Schultz will enter into the Company's standard form of indemnification agreement.
There are no arrangements or understandings between Mr. Schultz and any other persons pursuant to which he was elected as a member of the Company's Board. There are no family relationships between Mr. Schultz and any director, executive officer, or any person nominated or chosen by the Company to become a director or executive officer. Mr. Schultz is not a party to any current or proposed transaction with the Company for which disclosure is required under Item 404(a) of Regulation S-K.